These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 17152573)

  • 1. Use of fibrin sealants for the localized, controlled release of cefazolin.
    Tredwell S; Jackson JK; Hamilton D; Lee V; Burt HM
    Can J Surg; 2006 Oct; 49(5):347-52. PubMed ID: 17152573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro effects of proteases in human pancreatic juice on stability of liquid and carrier-bound fibrin sealants.
    Adelmeijer J; Porte RJ; Lisman T
    Br J Surg; 2013 Oct; 100(11):1498-504. PubMed ID: 24037572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of autologous fibrin sealants produced by CryoSeal and Vivostat in comparison to the homologous fibrin sealant product Tissucol/Tisseel.
    Buchta C; Hedrich HC; Macher M; Höcker P; Redl H
    Biomaterials; 2005 Nov; 26(31):6233-41. PubMed ID: 15921738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and Ex vivo Assessments of the Compatibility of Fibrin Sealant with Antimicrobial Compounds.
    Strickland AD; Lang C; Manhartseder S; Reichsoellner R; Valliant E; Schädl B; Gulle H; Slezak P
    Surg Infect (Larchmt); 2023 Feb; 24(1):82-90. PubMed ID: 36706256
    [No Abstract]   [Full Text] [Related]  

  • 5. Fibrin sealants in clinical practice.
    Albala DM
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():5-11. PubMed ID: 12869982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fibrin sealant composition on human neutrophil chemotaxis.
    Hanson AJ; Quinn MT
    J Biomed Mater Res; 2002 Sep; 61(3):474-81. PubMed ID: 12115473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antimicrobial activity of fibrin sealants containing antimicrobial agents.
    Nakaminami H; Suzuki Y; Suzuki R; Saito A; Motomura N; Noguchi N
    Surg Infect (Larchmt); 2014 Feb; 15(1):29-35. PubMed ID: 24283761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic proteins in human bile accelerate lysis of plasma clots and induce breakdown of fibrin sealants.
    Boonstra EA; Adelmeijer J; Verkade HJ; de Boer MT; Porte RJ; Lisman T
    Ann Surg; 2012 Aug; 256(2):306-12. PubMed ID: 22797359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell compatibility of fibrin sealants: in vitro study with cells involved in soft tissue repair.
    Macasev D; Diorio JP; Gugerell A; Goppelt A; Gulle H; Bittner M
    J Biomater Appl; 2011 Aug; 26(2):129-49. PubMed ID: 20624847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of tissue sealants to deliver antibiotics to an orthopaedic surgical site with a titanium implant.
    Cashman JD; Jackson JK; Mugabe C; Gilchrist S; Ball K; Tredwell S; Burt HM
    J Orthop Sci; 2013 Jan; 18(1):165-74. PubMed ID: 23096950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery.
    Greco F; de Palma L; Spagnolo N; Rossi A; Specchia N; Gigante A
    J Biomed Mater Res; 1991 Jan; 25(1):39-51. PubMed ID: 2019611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin matrices: The versatile therapeutic delivery systems.
    Ahmad E; Fatima MT; Hoque M; Owais M; Saleemuddin M
    Int J Biol Macromol; 2015 Nov; 81():121-36. PubMed ID: 26231328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A freeze-dried fibrin disc as a biodegradable drug release matrix.
    Kumar TR; Vasantha Bai M; Krishnan LK
    Biologicals; 2004 Mar; 32(1):49-55. PubMed ID: 15026025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Injectable drug carriers with sustained release of cis-platinum].
    Sugitachi A; Kashiwaba M; Takagane A; Asahi H; Saitoh K; Yoshida Y; Shindoh T; Matsuura N
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1851-4. PubMed ID: 14619537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrin sealants in supporting surgical techniques: The importance of individual components.
    Wozniak G
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():17-21. PubMed ID: 12869984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrin sealants in supporting surgical techniques: strength in factor XIII.
    Phillips M; Dickneite G; Metzner H
    Cardiovasc Surg; 2003 Aug; 11 Suppl 1():13-6. PubMed ID: 12869983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The release of cefazolin and gentamicin from biodegradable PLA/PGA beads.
    Wang G; Liu SJ; Ueng SW; Chan EC
    Int J Pharm; 2004 Apr; 273(1-2):203-12. PubMed ID: 15010144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of fibrin sealants in relation to their in vitro and in vivo properties.
    Dickneite G; Metzner H; Pfeifer T; Kroez M; Witzke G
    Thromb Res; 2003; 112(1-2):73-82. PubMed ID: 15013277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PCL-based honeycomb scaffolds as drug delivery systems for rhBMP-2.
    Rai B; Teoh SH; Hutmacher DW; Cao T; Ho KH
    Biomaterials; 2005 Jun; 26(17):3739-48. PubMed ID: 15621264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of fibrin-based sealants and gelatin-matrix hemostats in laparoscopic liver surgery.
    Saif R; Jacob M; Robinson S; Amer A; Kei-Hui D; Sen G; Manas D; White S
    Surg Laparosc Endosc Percutan Tech; 2011 Jun; 21(3):131-41. PubMed ID: 21654294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.